Cure or curse? Ambivalent attitudes towards neuroleptic medication in schizophrenia and non-schizophrenia patients

Steffen Moritz (University Medical Center Hamburg Eppendorf, Department of Psychiatry and Psychotherapy, Hamburg, Germany)
Cicek Hocaoglu (Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, The Netherlands)
Anne Karow (University Medical Center Hamburg Eppendorf, Department of Psychiatry and Psychotherapy, Hamburg, Germany)
Azra Deljkovic (University Medical Center Hamburg Eppendorf, Department of Psychiatry and Psychotherapy, Hamburg, Germany)
Peter Tonn (University Medical Center Hamburg Eppendorf, Department of Psychiatry and Psychotherapy, Hamburg, Germany)
Dieter Naber (University Medical Center Hamburg Eppendorf, Department of Psychiatry and Psychotherapy, Hamburg, Germany)

Mental Illness

ISSN: 2036-7465

Article publication date: 30 October 2009

375
This content is currently only available as a PDF

Abstract

Neuroleptic non-compliance remains a serious challenge for the treatment of psychosis. Non-compliance is predominantly attributed to side effects, lack of illness insight, reduced well-being or poor therapeutic alliance. However, other still neglected factors may also play a role. Further, little is known about whether psychiatric patients without psychosis who are increasingly prescribed neuroleptics differ in terms of medication compliance or about reasons for non-compliance by psychosis patients. As direct questioning is notoriously prone to social desirability biases, we conducted an anonymous survey. After a strict selection process blind to results, 95 psychiatric patients were retained for the final analyses (69 participants with a presumed diagnosis of schizophrenia psychosis, 26 without psychosis). Self-reported neuroleptic non-compliance was more prevalent in psychosis patients than non-psychosis patients. Apart from side effects and illness insight, main reasons for non-compliance in both groups were forgetfulness, distrust in therapist, and no subjective need for treatment. Other notable reasons were stigma and advice of relatives/acquaintances against neuroleptic medication. Gain from illness was a reason for non-compliance in 11-18% of the psychosis patients. Only 9% of all patients reported no side effects and full compliance and at the same time acknowledged that neuroleptics worked well for them. While pills were preferred over depot injections by the majority of patients, depot was judged as an alternative by a substantial subgroup. Although many patients acknowledge the need and benefits of neuroleptic medication, non-compliance was the norm rather than the exception in our samples.

Keywords

Citation

Moritz, S., Hocaoglu, C., Karow, A., Deljkovic, A., Tonn, P. and Naber, D. (2009), "Cure or curse? Ambivalent attitudes towards neuroleptic medication in schizophrenia and non-schizophrenia patients", Mental Illness, Vol. 1 No. 1, pp. 4-9. https://doi.org/10.4081/mi.2009.e2

Publisher

:

Emerald Publishing Limited

Copyright © 2009 S. Moritz et al.

License

This work is licensed under a Creative Commons Attribution 3.0 License (by-nc 3.0).


Corresponding author

Steffen Moritz, University Medical Center Hamburg Eppendorf, Department of Psychiatry and Psychotherapy, Martinistraβe 52, 20246 Hamburg, Germany. E-mail:

Related articles